Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126960511 | 12696051 | 1 | I | 20121116 | 20121116 | 20160829 | 20160829 | EXP | US-EMD SERONO-7176976 | EMD SERONO INC | 30.88 | YR | F | Y | 0.00000 | 20160830 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126960511 | 12696051 | 1 | PS | REBIF | INTERFERON BETA-1A | 1 | Subcutaneous | Y | 103780 | 44 | UG | INJECTION | TIW | ||||||
| 126960511 | 12696051 | 2 | SS | AMANTADINE | AMANTADINE | 1 | Y | 0 | 100 | MG | TID | ||||||||
| 126960511 | 12696051 | 3 | C | FEXOFENADINE | FEXOFENADINEFEXOFENADINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126960511 | 12696051 | 4 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | 0 | 30 | MG | QD | |||||||||
| 126960511 | 12696051 | 5 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 0 | 150 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126960511 | 12696051 | 1 | Multiple sclerosis |
| 126960511 | 12696051 | 2 | Fatigue |
| 126960511 | 12696051 | 3 | Hypersensitivity |
| 126960511 | 12696051 | 4 | Attention deficit/hyperactivity disorder |
| 126960511 | 12696051 | 5 | Feeling of relaxation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126960511 | 12696051 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126960511 | 12696051 | Balance disorder | |
| 126960511 | 12696051 | Fatigue | |
| 126960511 | 12696051 | Multiple sclerosis relapse | |
| 126960511 | 12696051 | Schizophrenia | |
| 126960511 | 12696051 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126960511 | 12696051 | 1 | 20120509 | 20121121 | 0 | |
| 126960511 | 12696051 | 2 | 20121114 | 20121121 | 0 |